Published in J Cereb Blood Flow Metab on May 01, 1990
Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function. Exp Neurol (2009) 0.97
Peroxynitrite and opiate antinociceptive tolerance: a painful reality. Arch Biochem Biophys (2008) 0.86
Calpain-Mediated Degradation of Drebrin by Excitotoxicity In vitro and In vivo. PLoS One (2015) 0.84
Time profile of calcium accumulation in hippocampus, striatum and frontoparietal cortex after transient forebrain ischemia in the gerbil. Acta Neuropathol (1992) 0.83
Mitochondrial dysfunction induced by nuclear poly(ADP-ribose) polymerase-1: a treatable cause of cell death in stroke. Transl Stroke Res (2013) 0.82
NADPH oxidase-2: linking glucose, acidosis, and excitotoxicity in stroke. Antioxid Redox Signal (2015) 0.80
Neuroprotective effect of GMP in hippocampal slices submitted to an in vitro model of ischemia. Cell Mol Neurobiol (2002) 0.80
CGS 19755 (Selfotel): A Novel Neuroprotective Agent Against CNS Injury. CNS Drug Rev (1996) 0.75
Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science (1984) 2.85
The nature and time course of the neuronal alterations resulting from oligaemia and hypoglycaemia in the brain of Macaca mulatta. Brain Res (1971) 2.60
Childhood hypoglycaemia. Br Med J (1972) 1.81
Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol (1973) 1.76
Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. Arch Neurol (1973) 1.65
The threshold and neuropathology of cerebral "anoxic-ischemic" cell change. Arch Neurol (1973) 1.57
Forebrain ischaemia with CA1 cell loss impairs epileptogenesis in the tetanus toxin limbic seizure model. Brain (1999) 1.53
Brain damage in the rhesus monkey resulting from profound arterial hypotension. I. Its nature, distribution and general physiological correlates. Brain Res (1969) 1.46
Anticonvulsant action of a 1,5-benzodiazepine, clobazam, in reflex epilepsy. Epilepsia (1978) 1.43
Cerebral metabolic changes during prolonged epileptic seizures in rats. J Neurochem (1977) 1.42
Epilepsy and gamma-aminobutyric acid-mediated inhibition. Int Rev Neurobiol (1975) 1.42
Physiology of status epilepticus in primates. Arch Neurol (1973) 1.40
The role of epileptic activity in hippocampal and "remote" cerebral lesions induced by kainic acid. Brain Res (1980) 1.30
Anticonvulsant action of excitatory amino acid antagonists. Science (1982) 1.29
Epileptic brain damage: the role of systemic factors that modify cerebral energy metabolism. Brain (1978) 1.29
Calcium overload in selectively vulnerable neurons of the hippocampus during and after ischemia: an electron microscopy study in the rat. J Cereb Blood Flow Metab (1984) 1.26
Na+ channels as targets for neuroprotective drugs. Trends Pharmacol Sci (1995) 1.25
Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase. Br J Pharmacol (1973) 1.24
Cerebral blood flow and metabolic rate early and late in prolonged epileptic seizures induced in rats by bicuculline. Brain (1976) 1.24
Mechanism of anticonvulsant action of valproate. Prog Neurobiol (1982) 1.23
A primate model for testing anticonvulsant drugs. Arch Neurol (1975) 1.18
Focal contralateral myoclonus produced by inhibition of GABA action in the caudate nucleus of rats. Brain (1978) 1.16
Focal myoclonus produced by injection of picrotoxin into the caudate nucleus of the rat. J Physiol (1975) 1.14
Photic and drug-induced epilepsy in the baboon (Papio papio): the effects of isoniazid, thiosemicarbazide, pyridoxine and amino-oxyacetic acid. Electroencephalogr Clin Neurophysiol (1970) 1.13
Enzymic and cerebral metabolic effects of 2-deoxy-D-glucose. J Neurochem (1973) 1.10
Factors influencing the frequency of fluorescence transients as markers of peri-infarct depolarizations in focal cerebral ischemia. Stroke (2000) 1.07
Intracellular calcium accumulation in rat hippocampus during seizures induced by bicuculline or L-allylglycine. Neuroscience (1983) 1.07
Benzodiazepine receptors and their relationship to the treatment of epilepsy. Epilepsia (1986) 1.06
The actions of snake venoms on nerve and muscle. The pharmacology of phospholipase A and of polypeptide toxins. Pharmacol Rev (1965) 1.05
Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Neuropharmacology (2000) 1.04
Anticonvulsant action in mice with sound-induced seizures of the optical isomers of gamma-vinyl GABA. Eur J Pharmacol (1983) 1.01
Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus. Exp Brain Res (1995) 1.00
Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effects of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-D-aspartate. Neuroscience (1986) 0.99
Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon. Psychopharmacology (Berl) (1982) 0.99
Kainic acid seizures and the reversibility of calcium loading in vulnerable neurons in the hippocampus. Neuropathol Appl Neurobiol (1984) 0.99
Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. Arzneimittelforschung (1984) 0.98
An adenosine analogue, 2-chloroadenosine, protects against long term development of ischaemic cell loss in the rat hippocampus. Neurosci Lett (1987) 0.97
Modulation of experimentally induced epilepsy by intracerebral grafts of fetal GABAergic neurons. Neuropsychologia (1990) 0.97
Status epilepticus: the reversibility of calcium loading and acute neuronal pathological changes in the rat hippocampus. Neuroscience (1984) 0.96
Long-term development of selective neuronal loss and the mechanism of protection by 2-amino-7-phosphonoheptanoate in a rat model of incomplete forebrain ischaemia. J Cereb Blood Flow Metab (1988) 0.94
Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br J Pharmacol (1988) 0.94
Intracellular sites of early calcium accumulation in the rat hippocampus during status epilepticus. Neurosci Lett (1982) 0.93
Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke (1995) 0.93
Antiepileptic action of excitatory amino acid antagonists in the photosensitive baboon, Papio papio. Neurosci Lett (1983) 0.92
Photically induced epilepsy in Papio papio as a model for drug studies. Adv Neurol (1975) 0.92
Decrease in excitatory transmission within the lateral habenula and the mediodorsal thalamus protects against limbic seizures in rats. Exp Neurol (1988) 0.91
Epileptic brain damage in adolescent baboons following seizures induced by allylgycine. Brain (1974) 0.91
Anticonvulsant activity of GABA uptake inhibitors and their prodrugs following central or systemic administration. Eur J Pharmacol (1983) 0.90
Effect of excitatory amino acid antagonists on the high pressure neurological syndrome in rats. Eur J Pharmacol (1984) 0.90
The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Res (1994) 0.90
The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Res (1991) 0.90
The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur J Pharmacol (1991) 0.90
Effects of fetal hippocampal field grafts on ischaemic-induced deficits in spatial navigation in the water maze. Neuroscience (1993) 0.89
Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia. Lancet (1988) 0.89
Altered expression of group I metabotropic glutamate receptors in the hippocampus of amygdala-kindled rats. Brain Res Mol Brain Res (1996) 0.89
Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen. Proc Natl Acad Sci U S A (1987) 0.89
Cell damage in epilepsy and the role of calcium in cytotoxicity. Adv Neurol (1986) 0.87
The strychnine-like action of curare and related compounds on the somatosensory evoked response of the rat cortex. Br J Pharmacol (1969) 0.87
Endocrine factors and glucose metabolism during prolonged seizures in baboons. Epilepsia (1979) 0.87
Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795). Neuropharmacology (2001) 0.86
Aspartate-like and glutamate-like immunoreactivities in the inferior olive and climbing fibre system: a light microscopic and semiquantitative electron microscopic study in rat and baboon (Papio anubis). Neuroscience (1990) 0.86
Gamma-aminobutyric acid and the search for new anticonvulsant drugs. Lancet (1978) 0.86
Convulsant and anticonvulsant actions in DBA/2 mice of compounds blocking the reuptake of GABA. Eur J Pharmacol (1979) 0.86
Regional cerebral blood flow in the rat during prolonged seizure activity. Brain Res (1980) 0.86
Selective excitotoxic pathology in the rat hippocampus. Neuropathol Appl Neurobiol (1993) 0.86
Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio. J Pharmacol Exp Ther (1990) 0.85
Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate. Eur J Pharmacol (1977) 0.85
Acute effects of sodium valproate and gamma-vinyl GABA on regional amino acid metabolism in the rat brain: incorporation of 2-[14C]glucose into amino acids. Neurochem Res (1982) 0.85
Effects of apomorphine, ergocornine and piribedil on audiogenic seizures in DBA/2 mice. Br J Pharmacol (1975) 0.85
The use of in vivo fluorescence image sequences to indicate the occurrence and propagation of transient focal depolarizations in cerebral ischemia. J Cereb Blood Flow Metab (1996) 0.85
Excitant and depressant actions of some new alkoxy derivatives of 2-aminomethyl-1, 4-benzodioxane on the central nervous system of the rabbit. Int J Neuropharmacol (1968) 0.85
Metabolic factors during prolonged seizures and their relation to nerve cell death. Adv Neurol (1983) 0.85
Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content. Life Sci (1983) 0.85
Susceptibility to pilocarpine-induced seizures in rats increases with age. Behav Brain Res (1988) 0.85
Electroencephalographic and behavioral effects of a GABA agonist (muscimol) on photosensitive epilepsy in the baboon, papio papio. Epilepsia (1979) 0.84
Anticonvulsant effect of reduced NMDA receptor expression in audiogenic DBA/2 mice. Epilepsy Res (1996) 0.84
Kynurenate inhibition of cell excitation decreases stroke size and deficits. Ann Neurol (1987) 0.84
2-Amino-7-phosphonoheptanoic acid (2-APH) infusion into entopeduncular nucleus protects against limbic seizures in rats. Neurosci Lett (1986) 0.84
Extracellular amino acid levels in hippocampus during pilocarpine-induced seizures. Epilepsy Res (1993) 0.84
Convulsant and anticonvulsant actions of agonists and antagonists of group III mGluRs. Neuroreport (1996) 0.83
Anticonvulsant actions of LY 367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid). Eur J Pharmacol (1999) 0.83
Neuronal loss and gliosis in the hippocampus following repetitive epileptic seizures induced in adolescent baboons by allylglycine. Brain Res (1972) 0.83
Global ischaemia: hippocampal pathology and spatial deficits in the water maze. Behav Brain Res (1994) 0.83
Physiological observations during prolonged epileptic seizures in primates and their relation to subsequent brain damage. J Physiol (1972) 0.83
A comparison of the anticonvulsant potency of (+/-) 2-amino-5-phosphonopentanoic acid and (+/-) 2-amino-7-phosphonoheptanoic acid. Neuroscience (1983) 0.83
Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigra. Eur J Pharmacol (1984) 0.83
Cerebral functional effects of 2-deoxy-D-glucose and 3-O-methylglucose in rhesus monkeys. Electroencephalogr Clin Neurophysiol (1973) 0.83
Focal injection of 2-amino-7-phosphonoheptanoic acid into prepiriform cortex protects against pilocarpine-induced limbic seizures in rats. Neurosci Lett (1986) 0.82
The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat. Brain Res (1992) 0.82
Cerebroprotective effect of the nitric oxide synthase inhibitors, 1-(2-trifluoromethylphenyl) imidazole and 7-nitro indazole, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab (1998) 0.82
Anticonvulsant profile of MDL 27,266: an orally active, broad-spectrum anticonvulsant agent. Epilepsy Res (1992) 0.82
Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres. Neurosci Lett (1989) 0.82
Clobazam: anticonvulsant action in animal models of epilepsy [proceedings]. Br J Clin Pharmacol (1979) 0.82
Anticonvulsant action in the photosensitive baboon, Papio papio, of a novel beta-carboline derivative, ZK 91296. Eur J Pharmacol (1983) 0.82
Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity? Psychopharmacology (Berl) (1986) 0.82
Excitatory amino acid antagonists and epilepsy. Biochem Soc Trans (1993) 0.82
Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice. Neuropharmacology (2001) 0.82
Regional changes in cerebral GABA concentration and convulsions produced by D and by L-allylglycine. J Neurochem (1978) 0.82
Non-competitive N-methyl-D-aspartate antagonists protect against sound-induced seizures in DBA/2 mice. Eur J Pharmacol (1989) 0.82
Behavioural and electrographic effects of L-5-hydroxytryptophan and D, L-parachlorophenyl-alanine on epileptic Senegalese baboon (Papio papio). Electroencephalogr Clin Neurophysiol (1972) 0.82